The overall aim of the Northwestern University Allergy-Immunology Research (NUAIR) Program is to train postdoctoral scientists in translational research, here defined as research of disease mechanisms that includes investigations in human subjects or human samples. The NUAIR Program builds on our Allergy-Immunology Fellowship, which has a long history of excellence in clinical and academic training. Unified efforts of established investigators in our Division with those from other Divisions and Departments have created a rich environment for translational research in the NUAIR program in which clinical and basic researchers, both faculty and trainees, collaborate and interact in weekly research and didactic activities. These collaborations have led to multidisciplinary translational research programs in several allergic diseases supported by well- equipped laboratories and a large number of research cores and facilities. Under the NUAIR Program, a steady state of 4 MD and/or PhD postgraduate trainees per year will receive 2 years of research training. Each will work together with a clinical research mentor and a basic research mentor to study mechanisms of allergic and immunological diseases, including studies of human subjects or their derived samples. In addition to well- structured research training and didactic activities strong mentoring and close monitoring of trainees' performances based on milestones will ensure proper progress during training. During the first period of funding, we have mentored 6 trainees; the three who have finished have all gone on to academic or industry research positions. Our retention plan includes support for trainees who remain in our Division as junior faculty members after T32-supported training, while they seek external funding support. Senior faculty members in the Allergy-Immunology Division have a strong record of mentoring trainees towards obtaining K awards (5 currently) and new R01 grants (4 junior faculty). We also offer programs to inspire medical students and residents to pursue careers in Allergy-Immunology. Taken together, our rapidly expanding and comprehensive Allergy-Immunology research environment will provide state-of-the-art training to highly qualified MD, MD/PhD and PhD postdoctoral trainees. These trainees will conduct collaborative translational research in Allergy- Immunology, initiating research careers that will help solve a severe national need for academic leaders in this field.
The NUAIR T32 Fellowship program is designed for MD and/or PhD trainees with an interest in advanced training in translational research in the field of Allergy-Immunology. Projects of trainees are those that have both clinical and laboratory components, and trainees have access to renowned mentors in both clinical and basic departments in order to develop a mentoring team with expertise in both realms to successfully complete projects and training. NUAIR is highly compliant with scientific, programmatic and social initiatives of the NIAID and the NIH, and has had a great deal of success in Fellowship training during its first funding period.
| Chiarella, Sergio E; Rabin, Erik E; Ostilla, Lorena A et al. (2018) ?T-catenin: A developmentally dispensable, disease-linked member of the ?-catenin family. Tissue Barriers 6:e1463896 |
| Robida, Piper A; Puzzovio, Pier Giorgio; Pahima, Hadas et al. (2018) Human eosinophils and mast cells: Birds of a feather flock together. Immunol Rev 282:151-167 |
| O'Sullivan, Jeremy A; Wei, Yadong; Carroll, Daniela J et al. (2018) Frontline Science: Characterization of a novel mouse strain expressing human Siglec-8 only on eosinophils. J Leukoc Biol 104:11-19 |
| O'Sullivan, Jeremy A; Bochner, Bruce S (2018) Eosinophils and eosinophil-associated diseases: An update. J Allergy Clin Immunol 141:505-517 |
| Wechsler, J B; Szabo, A; Hsu, C L et al. (2018) Histamine drives severity of innate inflammation via histamine 4 receptor in murine experimental colitis. Mucosal Immunol 11:861-870 |
| Chiarella, Sergio E; Grammer, Leslie C (2017) Immune deficiency in chronic rhinosinusitis: screening and treatment. Expert Rev Clin Immunol 13:117-123 |
| Stevens, Whitney W; Peters, Anju T; Hirsch, Annemarie G et al. (2017) Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease. J Allergy Clin Immunol Pract 5:1061-1070.e3 |
| Dispenza, Melanie C; Regan, Jennifer A; Bochner, Bruce S (2017) Potential applications of Bruton's tyrosine kinase inhibitors for the prevention of allergic reactions. Expert Rev Clin Immunol 13:921-923 |
| Stevens, Whitney W; Schleimer, Robert P (2016) Aspirin-Exacerbated Respiratory Disease as an Endotype of Chronic Rhinosinusitis. Immunol Allergy Clin North Am 36:669-680 |
| Stevens, Whitney W; Lee, Robert J; Schleimer, Robert P et al. (2015) Chronic rhinosinusitis pathogenesis. J Allergy Clin Immunol 136:1442-1453 |
Showing the most recent 10 out of 20 publications
